Skip to main content
Caplight Logo









Nu Eyne Co. Ltd.

Nu Eyne Co. Ltd.

Private
SeoulHealthcare & Life Scienceshttps://www.nueyne.com/

Last Round

Grant

Jun 26, 2023

Total Funding Raised

$21.63M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Nu Eyne Co. Ltd. is a healthtech company that develops and manufactures wearable electroceutical devices for treating chronic diseases.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Health IoT, Mental Health

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

electroceuticalsbioelectronic deviceneuromodulationwearable medical devicenerve stimulation devicetranscutaneous nerve stimulationTNSmigraine treatmentmigraine devicetrigeminal nerve stimulationADHD treatmentwearable therapynon-drug therapyat-home medical devicebioelectronic medicinemedical device hardwareFDA approval

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Nu Eyne Co. Ltd. Comparables

Compare Nu Eyne Co. Ltd. with similar companies based on industry and business-model similarity.

Nu Eyne Co. Ltd. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Ybrain
83%
Neurolief
82%
Theranica
79%

Nu Eyne Co. Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantJun 26, 2023
Series CNov 17, 2021
Series BMar 16, 2020
GrantNov 1, 2017
Series ASep 1, 2017

Key People

Founding team and executive leadership

Dohyoung Kim

CEO

Executive Team

Nu Eyne Co. Ltd. Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 25, 2026

    Monthly visitors increased 41% MoM.

  • Mar 2, 2026

    Monthly visitors increased 126% MoM, reaching 8.2K.

Nu Eyne Co. Ltd. Filings

Explore SEC and related filing metadata, where available.

Nu Eyne Co. Ltd. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Nu Eyne Co. Ltd.'s valuation, stock price, and market status.

Is Nu Eyne Co. Ltd. a public or private company?

Nu Eyne Co. Ltd. is a private company.

What is the current stock price of Nu Eyne Co. Ltd.?

Nu Eyne Co. Ltd. is a private company with no public stock price. No recent secondary market data is available.

How much is Nu Eyne Co. Ltd. worth (valuation)?

Valuation information for Nu Eyne Co. Ltd. is not publicly available.

Can I buy Nu Eyne Co. Ltd. stock?

Nu Eyne Co. Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Nu Eyne Co. Ltd.'s last funding round?

Nu Eyne Co. Ltd.'s most recent funding round was Grant on June 26, 2023.

Who are the main investors in Nu Eyne Co. Ltd.?

Key investors in Nu Eyne Co. Ltd. include InterVest, ATU Partners, L&S Venture Capital, Ministry of Trade, Industry and Energy, Venetus Asset Management.

Will Nu Eyne Co. Ltd. IPO soon?

No public IPO plans have been announced for Nu Eyne Co. Ltd..

How can I track Nu Eyne Co. Ltd. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Nu Eyne Co. Ltd.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSeoul
Employee Range8
Year Founded2017
Last FundingJun 26, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?